Sambi M, DeCarlo A, Malardier Jugroot C, Szewczuk M. Next-Generation Multimodality of Nanomedicine Therapy: Size and Structure Dependence of Folic Acid Conjugated Copolymers Actively Target Cancer Cells in Disabling Cell Division and Inducing Apoptosis. Cancers (Basel). 2019;11: pubmed publisher

Pais A, Degani H. Estrogen Receptor-Targeted Contrast Agents for Molecular Magnetic Resonance Imaging of Breast Cancer Hormonal Status. Front Oncol. 2016;6:100 pubmed publisher

Ray J, Mirata F, Pérollier C, Arotcarena M, Bayoudh S, Resmini M. Smart coumarin-tagged imprinted polymers for the rapid detection of tamoxifen. Anal Bioanal Chem. 2016;408:1855-61 pubmed publisher

Vitre B, Holland A, Kulukian A, Shoshani O, Hirai M, Wang Y, et al. Chronic centrosome amplification without tumorigenesis. Proc Natl Acad Sci U S A. 2015;112:E6321-30 pubmed publisher

Corriden R, Hollands A, Olson J, Derieux J, Lopez J, Chang J, et al. Tamoxifen augments the innate immune function of neutrophils through modulation of intracellular ceramide. Nat Commun. 2015;6:8369 pubmed publisher

Simões B, O Brien C, Eyre R, Silva A, Yu L, Sarmiento Castro A, et al. Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity. Cell Rep. 2015;12:1968-77 pubmed publisher

Takeuchi H, Mmeje C, Jinesh G, Taoka R, Kamat A. Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells. Oncol Rep. 2015;34:2738-44 pubmed publisher

Koh D, Powell D, Blake S, Hoffman J, Hopkins M, Feng X. Enhanced cytotoxicity in triple-negative and estrogen receptor‑positive breast adenocarcinoma cells due to inhibition of the transient receptor potential melastatin-2 channel. Oncol Rep. 2015;34:1589-98 pubmed publisher

Mahanta S, Paul S, Srivastava A, Pastor A, Kundu B, Chaudhuri T. Stable self-assembled nanostructured hen egg white lysozyme exhibits strong anti-proliferative activity against breast cancer cells. Colloids Surf B Biointerfaces. 2015;130:237-45 pubmed publisher

Ferrando Climent L, Cruz Morató C, Marco Urrea E, Vicent T, Sarrà M, Rodriguez Mozaz S, et al. Non conventional biological treatment based on Trametes versicolor for the elimination of recalcitrant anticancer drugs in hospital wastewater. Chemosphere. 2015;136:9-19 pubmed publisher

Bartonkova I, Novotna A, Dvorak Z. Novel stably transfected human reporter cell line AIZ-AR as a tool for an assessment of human androgen receptor transcriptional activity. PLoS ONE. 2015;10:e0121316 pubmed publisher

Roy N, Malik S, Villanueva K, Urano A, Lu X, von Figura G, et al. Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation. Genes Dev. 2015;29:658-71 pubmed publisher

Johnson J, Hamadeh I, Langaee T. Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for tamoxifen pharmacogenetic studies. J Natl Cancer Inst. 2015;107: pubmed publisher

Fukasawa K, Kagaya S, Maruyama S, Kuroiwa S, Masuda K, Kameyama Y, et al. A novel compound, NK150460, exhibits selective antitumor activity against breast cancer cell lines through activation of aryl hydrocarbon receptor. Mol Cancer Ther. 2015;14:343-54 pubmed publisher

Rai T, Cole J, Nelson D, Dikovskaya D, Faller W, Vizioli M, et al. HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasia. Genes Dev. 2014;28:2712-25 pubmed publisher

Hershman D. Perfecting breast-cancer treatment--incremental gains and musculoskeletal pains. N Engl J Med. 2015;372:477-8 pubmed publisher

Francis P, Regan M, Fleming G, Lang I, Ciruelos E, Bellet M, et al. Adjuvant ovarian suppression in premenopausal breast cancer. N Engl J Med. 2015;372:436-46 pubmed publisher

. Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies. J Natl Cancer Inst. 2014;107: pubmed publisher

Ko J, Chiu H, Syu J, Chen C, Jian Y, Huang Y, et al. Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells. Biochem Biophys Res Commun. 2015;456:506-12 pubmed publisher

Palta M, Palta P, Bhavsar N, Horton J, Blitzblau R. The use of adjuvant radiotherapy in elderly patients with early-stage breast cancer: changes in practice patterns after publication of Cancer and Leukemia Group B 9343. Cancer. 2015;121:188-93 pubmed publisher

Wickerham D, Vogel V. Breast cancer chemoprevention: the saga of underuse continues. J Natl Cancer Inst. 2015;107:399 pubmed publisher

Nichols H, DeRoo L, Scharf D, Sandler D. Risk-benefit profiles of women using tamoxifen for chemoprevention. J Natl Cancer Inst. 2015;107:354 pubmed publisher

Ma C, Yao M, Zhai Q, Jiao J, Yuan X, Poo M. SIRT1 suppresses self-renewal of adult hippocampal neural stem cells. Development. 2014;141:4697-709 pubmed publisher

Zhao B, Wu Z, Grillet N, Yan L, Xiong W, Harkins Perry S, et al. TMIE is an essential component of the mechanotransduction machinery of cochlear hair cells. Neuron. 2014;84:954-67 pubmed publisher

Ergun S, Tayeb T, Arslan A, Temiz E, Arman K, Safdar M, et al. The investigation of miR-221-3p and PAK1 gene expressions in breast cancer cell lines. Gene. 2015;555:377-81 pubmed publisher

Dabydeen S, Kang K, Díaz Cruz E, Alamri A, Axelrod M, Bouker K, et al. Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance. Carcinogenesis. 2015;36:122-32 pubmed publisher

Ono N, Ono W, Nagasawa T, Kronenberg H. A subset of chondrogenic cells provides early mesenchymal progenitors in growing bones. Nat Cell Biol. 2014;16:1157-67 pubmed publisher

Luciani Torres M, Moore D, Goodson W, Dairkee S. Exposure to the polyester PET precursor--terephthalic acid induces and perpetuates DNA damage-harboring non-malignant human breast cells. Carcinogenesis. 2015;36:168-76 pubmed publisher

Hu R, Warri A, Jin L, Zwart A, Riggins R, Fang H, et al. NF-κB signaling is required for XBP1 (unspliced and spliced)-mediated effects on antiestrogen responsiveness and cell fate decisions in breast cancer. Mol Cell Biol. 2015;35:379-90 pubmed publisher

Jankowitz R, Puhalla S, Davidson N. Should we embrace or ablate our urge to (ovarian) suppress?. J Clin Oncol. 2014;32:3920-2 pubmed publisher

Lim A, Shin K, Zhao C, Kawano S, Beachy P. Spatially restricted Hedgehog signalling regulates HGF-induced branching of the adult prostate. Nat Cell Biol. 2014;16:1135-45 pubmed publisher

Tevaarwerk A, Wang M, Zhao F, Fetting J, Cella D, Wagner L, et al. Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2014;32:3948-58 pubmed publisher

Hsu L, Liu K, Tsai M, Wu C, Feng A, Chu N, et al. Estrogen adversely affects the prognosis of patients with lung adenocarcinoma. Cancer Sci. 2015;106:51-9 pubmed publisher

Nozik Grayck E, Woods C, Taylor J, Benninger R, Johnson R, Villegas L, et al. Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2014;307:L868-76 pubmed publisher

Reid J, Goetz M, Buhrow S, Walden C, Safgren S, Kuffel M, et al. Pharmacokinetics of endoxifen and tamoxifen in female mice: implications for comparative in vivo activity studies. Cancer Chemother Pharmacol. 2014;74:1271-8 pubmed publisher

Ishihara Y, Itoh K, Ishida A, Yamazaki T. Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway. J Steroid Biochem Mol Biol. 2015;145:85-93 pubmed publisher

Chlebowski R, Pan K. Exemestane with ovarian suppression in premenopausal breast cancer. N Engl J Med. 2014;371:1358 pubmed publisher

Amoroso V, Berruti A, Simoncini E. Exemestane with ovarian suppression in premenopausal breast cancer. N Engl J Med. 2014;371:1357 pubmed publisher

Maximov P, McDaniel R, Fernandes D, Bhatta P, Korostyshevskiy V, Curpan R, et al. Pharmacological relevance of endoxifen in a laboratory simulation of breast cancer in postmenopausal patients. J Natl Cancer Inst. 2014;106: pubmed publisher

Printz C. More treatment options for women with hormone receptor-positive breast cancer: guideline update, studies lead to advances in care. Cancer. 2014;120:2939-40 pubmed publisher

Gerl M, Vöckl J, Kurt B, van Veen T, Kurtz A, Wagner C. Inducible deletion of connexin 40 in adult mice causes hypertension and disrupts pressure control of renin secretion. Kidney Int. 2015;87:557-63 pubmed publisher

Liu C, Hung M, Wang D, Chu P, Su J, Teng T, et al. Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cells. Breast Cancer Res. 2014;16:431 pubmed publisher

Yoldas O, Karaca T, Bilgin B, Yılmaz Ö, Simşek G, Alici I, et al. Tamoxifen citrate: a glimmer of hope for silicosis. J Surg Res. 2015;193:429-34 pubmed publisher

Fu X, Creighton C, Biswal N, Kumar V, Shea M, Herrera S, et al. Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase. Breast Cancer Res. 2014;16:430 pubmed publisher

Fan P, Cunliffe H, Griffith O, Agboke F, Ramos P, Gray J, et al. Identification of gene regulation patterns underlying both oestrogen- and tamoxifen-stimulated cell growth through global gene expression profiling in breast cancer cells. Eur J Cancer. 2014;50:2877-86 pubmed publisher

Scripture Adams D, Damle S, Li L, Elihu K, Qin S, Arias A, et al. GATA-3 dose-dependent checkpoints in early T cell commitment. J Immunol. 2014;193:3470-91 pubmed publisher

Mulherkar S, Uddin M, Couvillon A, Sillitoe R, Tolias K. The small GTPases RhoA and Rac1 regulate cerebellar development by controlling cell morphogenesis, migration and foliation. Dev Biol. 2014;394:39-53 pubmed publisher

Yaqub F. A new combination therapy for premenopausal breast cancer. Lancet Oncol. 2014;15:e311 pubmed

Bourgier C, Lemanski C, Romieu G, Ozsahin M, Azria D. [Breast cancer: radiotherapy and estrogen signaling]. Bull Cancer. 2014;101:714-7 pubmed publisher

Hamaguchi R, Tanimoto T, Kuroda Y. Putative biomarker for phospholipid accumulation in cultured cells treated with phospholipidosis-inducing drugs: alteration of the phosphatidylinositol composition detected using high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;967:110-7 pubmed publisher

Wenhui Z, Shuo L, Dabei T, Ying P, Zhipeng W, Lei Z, et al. Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment. Eur J Endocrinol. 2014;171:527-33 pubmed publisher

Duan L, Danzer B, Levenson V, Maki C. Critical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cells. Cancer Lett. 2014;353:290-300 pubmed publisher

Province M, Altman R, Klein T. Interpreting the CYP2D6 results from the International Tamoxifen Pharmacogenetics Consortium. Clin Pharmacol Ther. 2014;96:144-6 pubmed publisher

Goetz M, Ingle J. CYP2D6 genotype and tamoxifen: considerations for proper nonprospective studies. Clin Pharmacol Ther. 2014;96:141-4 pubmed publisher

Berry D. CYP2D6 genotype and adjuvant tamoxifen. Clin Pharmacol Ther. 2014;96:138-40 pubmed publisher

Bull S, Bin J, Beaumont E, Boutet A, Krimpenfort P, Sadikot A, et al. Progressive disorganization of paranodal junctions and compact myelin due to loss of DCC expression by oligodendrocytes. J Neurosci. 2014;34:9768-78 pubmed publisher

Oosterkamp H, Hijmans E, Brummelkamp T, Canisius S, Wessels L, Zwart W, et al. USP9X downregulation renders breast cancer cells resistant to tamoxifen. Cancer Res. 2014;74:3810-20 pubmed publisher

Rugo H. Hormone therapy in premenopausal women with early-stage breast cancer. N Engl J Med. 2014;371:175-6 pubmed publisher

Castillo D, Seidel K, Salcedo E, Ahn C, De Sauvage F, Klein O, et al. Induction of ectopic taste buds by SHH reveals the competency and plasticity of adult lingual epithelium. Development. 2014;141:2993-3002 pubmed publisher

Di Girolamo N, Bobba S, Raviraj V, Delic N, Slapetova I, Nicovich P, et al. Tracing the fate of limbal epithelial progenitor cells in the murine cornea. Stem Cells. 2015;33:157-69 pubmed publisher

Smeets M, DeLuca E, Wall M, Quach J, Chalk A, Deans A, et al. The Rothmund-Thomson syndrome helicase RECQL4 is essential for hematopoiesis. J Clin Invest. 2014;124:3551-65 pubmed publisher

Nicolao M, Elissondo M, Denegri G, Goya A, Cumino A. In vitro and in vivo effects of tamoxifen against larval stage Echinococcus granulosus. Antimicrob Agents Chemother. 2014;58:5146-54 pubmed publisher

Günschmann C, Chiticariu E, Garg B, Hiz M, Mostmans Y, Wehner M, et al. Transgenic mouse technology in skin biology: inducible gene knockout in mice. J Invest Dermatol. 2014;134:1-4 pubmed publisher

Gryn S, Teft W, Kim R. Profound reduction in the tamoxifen active metabolite endoxifen in a patient on phenytoin for epilepsy compared with a CYP2D6 genotype matched cohort. Pharmacogenet Genomics. 2014;24:367-9 pubmed publisher

Hatkevich T, Ramos J, Santos Sanchez I, Patel Y. A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells. Exp Cell Res. 2014;327:331-9 pubmed publisher

Ribeiro M, Santos A, Custódio J. Mitochondria: the gateway for tamoxifen-induced liver injury. Toxicology. 2014;323:10-8 pubmed publisher

Pagani O, Regan M, Walley B, Fleming G, Colleoni M, Lang I, et al. Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. N Engl J Med. 2014;371:107-18 pubmed publisher

Chen Y, Chang Y, Pan S, Chou Y, Chang F, Yeh P, et al. Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury. J Am Soc Nephrol. 2014;25:2847-58 pubmed publisher

Phuong N, Lim S, Kim Y, Kang K. Aromatase induction in tamoxifen-resistant breast cancer: Role of phosphoinositide 3-kinase-dependent CREB activation. Cancer Lett. 2014;351:91-9 pubmed publisher

Wilisch Neumann A, Pachow D, Wallesch M, Petermann A, Bohmer F, Kirches E, et al. Re-evaluation of cytostatic therapies for meningiomas in vitro. J Cancer Res Clin Oncol. 2014;140:1343-52 pubmed publisher

Orleans R, Li L, Kim M, Guo J, Sobhan M, Soule L, et al. FDA approval of paroxetine for menopausal hot flushes. N Engl J Med. 2014;370:1777-9 pubmed publisher

Tolson K, Gemelli T, Meyer D, Yazdani U, Kozlitina J, Zinn A. Inducible neuronal inactivation of Sim1 in adult mice causes hyperphagic obesity. Endocrinology. 2014;155:2436-44 pubmed publisher

Yu M, Wang J, Liu W, Qin J, Zhou Q, Wang Y, et al. Effects of tamoxifen on the sex determination gene and the activation of sex reversal in the developing gonad of mice. Toxicology. 2014;321:89-95 pubmed publisher

Martelli G, Boracchi P, Orenti A, Lozza L, Maugeri I, Vetrella G, et al. Axillary dissection versus no axillary dissection in older T1N0 breast cancer patients: 15-year results of trial and out-trial patients. Eur J Surg Oncol. 2014;40:805-12 pubmed publisher

Degreef I, Tejpar S, Sciot R, De Smet L. High-dosage tamoxifen as neoadjuvant treatment in minimally invasive surgery for Dupuytren disease in patients with a strong predisposition toward fibrosis: a randomized controlled trial. J Bone Joint Surg Am. 2014;96:655-62 pubmed publisher

Polyak K. Tumor heterogeneity confounds and illuminates: a case for Darwinian tumor evolution. Nat Med. 2014;20:344-6 pubmed publisher

Kim H, Koh B, Yu J, Lee J, Son B, Kim S, et al. Changes in serum hydroxyvitamin D levels of breast cancer patients during tamoxifen treatment or chemotherapy in premenopausal breast cancer patients. Eur J Cancer. 2014;50:1403-11 pubmed publisher

Knoop A, Lænkholm A, Jensen M, Nielsen K, Andersen J, Nielsen D, et al. Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial. Eur J Cancer. 2014;50:1412-21 pubmed publisher

Schweikart K, Eldridge S, Safgren S, Parman T, Reid J, Ames M, et al. Comparative uterotrophic effects of endoxifen and tamoxifen in ovariectomized Sprague-Dawley rats. Toxicol Pathol. 2014;42:1188-96 pubmed publisher

Wilson C, Gamper I, Perfetto A, Auw J, Littlewood T, Evan G. The kinetics of ER fusion protein activation in vivo. Oncogene. 2014;33:4877-80 pubmed publisher

Kim J, Cho N, Jeyanth J, Kim W, Lee S, Gweon H, et al. Smaller reduction in 3D breast density associated with subsequent cancer recurrence in patients with breast cancer receiving adjuvant tamoxifen therapy. AJR Am J Roentgenol. 2014;202:912-21 pubmed publisher

Zheng K, Chen M, Xiang Y, Ma K, Jin F, Wang X, et al. Inhibition of herpes simplex virus type 1 entry by chloride channel inhibitors tamoxifen and NPPB. Biochem Biophys Res Commun. 2014;446:990-6 pubmed publisher

van de Water W, Kiderlen M, Bastiaannet E, Siesling S, Westendorp R, Van De Velde C, et al. External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer. J Natl Cancer Inst. 2014;106:dju051 pubmed publisher

Wang J, Hu F, Luo Y, Luo H, Huang N, Cheng F, et al. Estrogenic and anti-estrogenic activities of hispolon from Phellinus lonicerinus (Bond.) Bond. et sing. Fitoterapia. 2014;95:93-101 pubmed publisher

Tsai Y, Wang C, Leung P, Lin K, Chio C, Hu C, et al. Extracellular signal-regulated kinase 1/2 is involved in a tamoxifen neuroprotective effect in a lateral fluid percussion injury rat model. J Surg Res. 2014;189:106-16 pubmed publisher

Paul D, Grevengoed T, Pascual F, Ellis J, Willis M, Coleman R. Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin. Biochim Biophys Acta. 2014;1841:880-7 pubmed publisher

Ozcan R, Topkara A, Bagdatli D, Ozkan A, Aydin O, Celebi T. Effects of tamoxifen on survival of cutaneous and myocutaneous flap (experimental study). Eur Rev Med Pharmacol Sci. 2014;18:493-9 pubmed

Chau Y, Bandiera R, Serrels A, Martínez Estrada O, Qing W, Lee M, et al. Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source. Nat Cell Biol. 2014;16:367-75 pubmed publisher

Lapid O, Klinkenbijl J, Oomen M, Van Wingerden J. Gynaecomastia surgery in the Netherlands: what, why, who, where…. J Plast Reconstr Aesthet Surg. 2014;67:702-6 pubmed publisher

Donnelly L, Evans D, Wiseman J, Fox J, Greenhalgh R, Affen J, et al. Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic. Br J Cancer. 2014;110:1681-7 pubmed publisher

Seruga B, Zadnik V, Kuhar C, Marinko T, Cufer T, Zakotnik B, et al. Association of aromatase inhibitors with coronary heart disease in women with early breast cancer. Cancer Invest. 2014;32:99-104 pubmed publisher

Lavado A, Oliver G. Jagged1 is necessary for postnatal and adult neurogenesis in the dentate gyrus. Dev Biol. 2014;388:11-21 pubmed publisher

Hernandez Ramon E, Sandoval N, John K, Cline J, Wood C, Woodward R, et al. Tamoxifen-DNA adduct formation in monkey and human reproductive organs. Carcinogenesis. 2014;35:1172-6 pubmed publisher

Schrading S, Schild H, Kühr M, Kuhl C. Effects of tamoxifen and aromatase inhibitors on breast tissue enhancement in dynamic contrast-enhanced breast MR imaging: a longitudinal intraindividual cohort study. Radiology. 2014;271:45-55 pubmed publisher

Jordan G, Carson C, Lipshultz L. Minimally invasive treatment of Peyronie's disease: evidence-based progress. BJU Int. 2014;114:16-24 pubmed publisher

. Experts add second drug to breast cancer prevention regimen. Harv Womens Health Watch. 2013;21:8 pubmed

. Summaries for patients. Using medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force. Ann Intern Med. 2013;159:I-28 pubmed

Sakurai K, Fujisaki S, Maeda T, Nagashima S, Hara Y, Tomita R, et al. [Successful treatment of neuroendocrine ductal carcinoma in situ with loco-regional therapy]. Gan To Kagaku Ryoho. 2013;40:2363-5 pubmed

Sakurai K, Fujisaki S, Maeda T, Nagashima S, Hara Y, Tomita R, et al. [Diagnosis of ductal carcinoma in situ with interruption of the anterior border of the mammary gland by ultrasonography-a case report]. Gan To Kagaku Ryoho. 2013;40:2360-2 pubmed

Gilleard O, Askouni E, Tavsanoglu Y, Jones M. Venous thromboembolism prophylaxis for abdominal free tissue breast reconstruction: a multicenter survey. J Plast Reconstr Aesthet Surg. 2014;67:733-5 pubmed publisher

Fry C, Lee J, Jackson J, Kirby T, Stasko S, Liu H, et al. Regulation of the muscle fiber microenvironment by activated satellite cells during hypertrophy. FASEB J. 2014;28:1654-65 pubmed publisher

Pinkerton J, Thomas S. Use of SERMs for treatment in postmenopausal women. J Steroid Biochem Mol Biol. 2014;142:142-54 pubmed publisher

Mahon S, Kaplan M. Paroxetine approval. Am J Nurs. 2014;114:10 pubmed publisher

El Ashmawy N, Khalil R. A review on the role of L-carnitine in the management of tamoxifen side effects in treated women with breast cancer. Tumour Biol. 2014;35:2845-55 pubmed publisher

Busch S, Acar A, Magnusson Y, Gregersson P, Ryden L, Landberg G. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer. Oncogene. 2015;34:27-38 pubmed publisher

. Breakthrough in ER+ breast cancer. Specific gene's shutdown is detectable in blood; indicates cancer cell vulnerability, thus enabling earlier treatment. Duke Med Health News. 2013;19:7 pubmed

Samuji M, O Sullivan R, Shireen R. Uterine sarcoma after tamoxifen therapy for breast cancer. Ir Med J. 2013;106:246 pubmed

. Addendum: Ospemifene (Osphena) for dyspareunia (Med Lett Drugs Ther 2013; 55:55). Med Lett Drugs Ther. 2013;55:84 pubmed

Firth M, Madera S, Beaulieu A, Gasteiger G, Castillo E, Schluns K, et al. Nfil3-independent lineage maintenance and antiviral response of natural killer cells. J Exp Med. 2013;210:2981-90 pubmed publisher

Bossart M, Hadji P, Klar M, Kieback D, Hasenburg A. Effect of prior chemotherapy regimens on the efficacy of endocrine therapy within a German cohort of the TEAM trial. J Cancer Res Clin Oncol. 2014;140:117-26 pubmed publisher

Zhao L, Zhu S, Gao Y, Wang Y. Two-gene expression ratio as predictor for breast cancer treated with tamoxifen: evidence from meta-analysis. Tumour Biol. 2014;35:3113-7 pubmed publisher

Castellano E, Sheridan C, Thin M, Nye E, Spencer Dene B, Diefenbacher M, et al. Requirement for interaction of PI3-kinase p110? with RAS in lung tumor maintenance. Cancer Cell. 2013;24:617-30 pubmed publisher

Kahl S, Roden M, Mörike K, Müssig K. [Rare cause for severe hypertriglyceridemia - case 9/2013]. Dtsch Med Wochenschr. 2013;138:2410 pubmed publisher

Merenbakh Lamin K, Ben Baruch N, Yeheskel A, Dvir A, Soussan Gutman L, Jeselsohn R, et al. D538G mutation in estrogen receptor-?: A novel mechanism for acquired endocrine resistance in breast cancer. Cancer Res. 2013;73:6856-64 pubmed publisher

Tata P, Mou H, Pardo Saganta A, Zhao R, Prabhu M, Law B, et al. Dedifferentiation of committed epithelial cells into stem cells in vivo. Nature. 2013;503:218-23 pubmed publisher

Rockich B, Hrycaj S, Shih H, Nagy M, Ferguson M, Kopp J, et al. Sox9 plays multiple roles in the lung epithelium during branching morphogenesis. Proc Natl Acad Sci U S A. 2013;110:E4456-64 pubmed publisher

Pritchard K. Symptoms and cancer outcome in adjuvant endocrine therapy for breast cancer: why are they associated?. J Clin Oncol. 2013;31:4476 pubmed publisher

Fontein D, Van De Velde C. Reply to K.I. Pritchard. J Clin Oncol. 2013;31:4477-9 pubmed publisher

Tsoutsou P, Jeanneret Sozzi W, Ozsahin M, Delaloye J, Bourhis J. Radiotherapy options after breast-conserving surgery: how can selection of patients be refined?. J Clin Oncol. 2013;31:4570-1 pubmed publisher

Kaidar Person O, Kuten A, Walker G, Morgan D. Should radiotherapy be omitted in women age 70 years or older with early breast cancer?. J Clin Oncol. 2013;31:4569 pubmed publisher

Hughes K, Schnaper L, Bellon J, Cirrincione C, Berry D, McCormick B, et al. Reply to P.G. Tsoutsou et al, o. Kaidar-Person et al, and A. Courdi et al. J Clin Oncol. 2013;31:4571-3 pubmed publisher

Smith B, Buchholz T. Reply to P.G. Tsoutsou et al and O. Kaidar-Person et al. J Clin Oncol. 2013;31:4573 pubmed publisher

Taylor A, Kalathy V, Habiba M. Estradiol and tamoxifen enhance invasion of endometrial stromal cells in a three-dimensional coculture model of adenomyosis. Fertil Steril. 2014;101:288-93 pubmed publisher

McGlynn L, Zino S, MacDonald A, Curle J, Reilly J, Mohammed Z, et al. SIRT2: tumour suppressor or tumour promoter in operable breast cancer?. Eur J Cancer. 2014;50:290-301 pubmed publisher

Swiderska Syn M, Syn W, Xie G, Kruger L, Machado M, Karaca G, et al. Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy. Gut. 2014;63:1333-44 pubmed publisher

Manni A, Richie J, Xu H, Washington S, Aliaga C, Bruggeman R, et al. Influence of omega-3 fatty acids on Tamoxifen-induced suppression of rat mammary carcinogenesis. Int J Cancer. 2014;134:1549-57 pubmed publisher

Spanheimer P, CYR A, Gillum M, Woodfield G, Askeland R, Weigel R. Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy. Ann Surg. 2014;259:793-9 pubmed publisher

Hashem F, Nasr M, Khairy A. In vitro cytotoxicity and bioavailability of solid lipid nanoparticles containing tamoxifen citrate. Pharm Dev Technol. 2014;19:824-32 pubmed publisher

Sugerman D. JAMA patient page. Tamoxifen update. JAMA. 2013;310:866 pubmed publisher

Anderson S, Cink T. Case report of papillary breast carcinoma, cystic. S D Med. 2013;66:265-6 pubmed

Lorange E, Harmanli O, Cao Q, Jones K. Vaginal myofibroblastoma with prostatic glands: is there an association with tamoxifen use? A case report. J Reprod Med. 2013;58:344-6 pubmed

Zanini G, Fontanella B, Racheli M, Bortolotti M, Pasini G. [Tamoxifen treatment and pulmunary embolism: a case report and literature review]. Monaldi Arch Chest Dis. 2013;80:42-4 pubmed

Connolly R, Stearns V. Postmenopausal hormone receptor-positive advanced breast cancer. Oncology (Williston Park). 2013;27:571-2, 574, 576 passim pubmed

Sancho M, Di Gregorio A, George N, Pozzi S, Sánchez J, Pernaute B, et al. Competitive interactions eliminate unfit embryonic stem cells at the onset of differentiation. Dev Cell. 2013;26:19-30 pubmed publisher

Okazaki M, Okazaki A, Sato F, Watanabe Y, Yamagishi H. [Two cases of multiple liver metastases breast cancer successfully treated with combination chemotherapy by S-1, vinorelbine and medroxyprogesterone]. Gan To Kagaku Ryoho. 2013;40:769-71 pubmed

Pritchard K. Endocrine therapy: is the first generation of targeted drugs the last?. J Intern Med. 2013;274:144-52 pubmed publisher

Wylie S, Ravichandran D. A UK national survey of breast surgeons on primary endocrine therapy of early operable breast cancer. Ann R Coll Surg Engl. 2013;95:353-6 pubmed publisher

. Ospemifene (Osphena) for dyspareunia. Med Lett Drugs Ther. 2013;55:55-6 pubmed

Fricker F, Antunes Martins A, Galino J, Paramsothy R, La Russa F, Perkins J, et al. Axonal neuregulin 1 is a rate limiting but not essential factor for nerve remyelination. Brain. 2013;136:2279-97 pubmed publisher

Wise J. NICE recommends preventive drugs for breast cancer. BMJ. 2013;346:f4116 pubmed publisher

Shen L, Zeng F, Hong L, Zhang G, Mai R. Vulvar melanoma and endometrial polyp following breast carcinoma: a case report. Eur J Gynaecol Oncol. 2013;34:197-9 pubmed

Fox P, Hudson M, Brown C, Lord S, Gebski V, de Souza P, et al. Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. Br J Cancer. 2013;109:147-53 pubmed publisher

Davies C, Gray R, Pan H, Peto R. Tamoxifen therapy for patients with breast cancer - Authors' reply. Lancet. 2013;381:2078-9 pubmed publisher

Litton J, Buzdar A, Mac Gregor M, Gonzalez Angulo A, Hortobagyi G. Tamoxifen therapy for patients with breast cancer. Lancet. 2013;381:2077-8 pubmed publisher

Guenthner C, Miyamichi K, Yang H, Heller H, Luo L. Permanent genetic access to transiently active neurons via TRAP: targeted recombination in active populations. Neuron. 2013;78:773-84 pubmed publisher

Ribeiro M, Santos A, Santos M, Custódio J. Effects of all-trans-retinoic acid on the permeability transition and bioenergetic functions of rat liver mitochondria in combination with endoxifen. Life Sci. 2013;93:96-107 pubmed publisher

Cai T, Seymour M, Zhang H, Pereira F, Groves A. Conditional deletion of Atoh1 reveals distinct critical periods for survival and function of hair cells in the organ of Corti. J Neurosci. 2013;33:10110-22 pubmed publisher

Popp S, Joffroy C, Stope M, Buck M, Fritz P, Knabbe C. Antiestrogens suppress effects of transforming growth factor-β in breast cancer cells via the signaling axis estrogen receptor-α and Y-box Binding Protein-1. Anticancer Res. 2013;33:2473-80 pubmed

Nau J. [The story of Osphena and dyspareunia]. Rev Med Suisse. 2013;9:1062-3 pubmed

Roguljić H, Matthews B, Yang W, Cvija H, Mina M, Kalajzic I. In vivo identification of periodontal progenitor cells. J Dent Res. 2013;92:709-15 pubmed publisher

Lv W, Liu J, Lu D, Flockhart D, Cushman M. Synthesis of mixed (E,Z)-, (E)-, and (Z)-norendoxifen with dual aromatase inhibitory and estrogen receptor modulatory activities. J Med Chem. 2013;56:4611-8 pubmed publisher

Blitz E, Sharir A, Akiyama H, Zelzer E. Tendon-bone attachment unit is formed modularly by a distinct pool of Scx- and Sox9-positive progenitors. Development. 2013;140:2680-90 pubmed publisher

Yi E, Yoo H, Noh K, Han S, Lee H, Lee J, et al. BST-2 is a potential activator of invasion and migration in tamoxifen-resistant breast cancer cells. Biochem Biophys Res Commun. 2013;435:685-90 pubmed publisher

Hester M, Danzer S. Accumulation of abnormal adult-generated hippocampal granule cells predicts seizure frequency and severity. J Neurosci. 2013;33:8926-36 pubmed publisher

Smith B, Buchholz T. Radiation treatments after breast-conserving therapy for elderly patients. J Clin Oncol. 2013;31:2367-8 pubmed publisher

Hughes K, Schnaper L, Bellon J, Cirrincione C, Berry D, McCormick B, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31:2382-7 pubmed publisher

Hepel J, Wazer D. Should a woman age 70 to 80 years receive radiation after breast-conserving surgery?. J Clin Oncol. 2013;31:2377-81 pubmed publisher

Nagahara Y, Takeyoshi M, Sakemoto S, Shiina I, Nakata K, Fujimori K, et al. Novel tamoxifen derivative Ridaifen-B induces Bcl-2 independent autophagy without estrogen receptor involvement. Biochem Biophys Res Commun. 2013;435:657-63 pubmed publisher

von Figura G, Morris J, Wright C, Hebrok M. Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation. Gut. 2014;63:656-64 pubmed publisher

Ma D, Tremblay P, Mahngar K, Collins J, Hudlicky T, Pandey S. Selective cytotoxicity against human osteosarcoma cells by a novel synthetic C-1 analogue of 7-deoxypancratistatin is potentiated by curcumin. PLoS ONE. 2011;6:e28780 pubmed publisher

Thorner A, Parker J, Hoadley K, Perou C. Potential tumor suppressor role for the c-Myb oncogene in luminal breast cancer. PLoS ONE. 2010;5:e13073 pubmed publisher

Fang Y, Pan Z, Li L, Lu Z, Zhang L, Wan D. MMP7 expression regulated by endocrine therapy in ERbeta-positive colon cancer cells. J Exp Clin Cancer Res. 2009;28:132 pubmed publisher

Gudbrandsen O, Rost T, Berge R. Causes and prevention of tamoxifen-induced accumulation of triacylglycerol in rat liver. J Lipid Res. 2006;47:2223-32 pubmed

Smedira H. Practical issues in counseling healthy women about their breast cancer risk and use of tamoxifen citrate. Arch Intern Med. 2000;160:3034-42 pubmed

Harland J, Liburdy R. Environmental magnetic fields inhibit the antiproliferative action of tamoxifen and melatonin in a human breast cancer cell line. Bioelectromagnetics. 1997;18:555-62 pubmed

Paulsen G, Strickert T, Marthinsen A, Lundgren S. Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro. Acta Oncol. 1996;35:1011-9 pubmed